- Home
- BLTE vs CRNX Comparison
BLTE vs CRNX Comparison
Compare BLTE & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BLTE | CRNX |
|---|---|---|
| Founded | 2018 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.1B |
| IPO Year | 2022 | 2018 |
Fundamental Metrics
Financial Performance| Metric | BLTE | CRNX |
|---|---|---|
| Price | $158.00 | $53.37 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 11 |
| Target Price | ★ $156.00 | $71.00 |
| AVG Volume (30 Days) | 250.7K | ★ 1.5M |
| Earning Date | 11-10-2025 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,535,000.00 |
| Revenue This Year | N/A | $425.41 |
| Revenue Next Year | N/A | $943.30 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 47.74 |
| 52 Week Low | $49.00 | $24.10 |
| 52 Week High | $170.25 | $57.99 |
Technical Indicators
Market Signals| Indicator | BLTE | CRNX |
|---|---|---|
| Relative Strength Index (RSI) | 56.72 | 65.90 |
| Support Level | $153.56 | $43.40 |
| Resistance Level | $170.25 | $57.99 |
| Average True Range (ATR) | 6.34 | 2.70 |
| MACD | -1.18 | 0.48 |
| Stochastic Oscillator | 28.64 | 70.77 |
Price Performance
Historical ComparisonAbout BLTE Belite Bio Inc
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.